GLANCE STOCKS NEWS EUROPE-Astra up in weak pharma after Citi support

Date : 10/09/2008 @ 5:07AM
Source : TFN
Stock : Glaxosmithkline (GSK)
Quote : 1171.5  1.5 (0.13%) @ 11:35AM
<< BackQuote Chart

 



GLANCE STOCKS NEWS EUROPE-Astra up in weak pharma after Citi support

        -     STOCKS NEWS                     Reuters                    Results
diary 
       Stocks on the move   Real-time Equity News  
        
       08:45GMT 09Oct2008-Astra up in weak pharma after Citi support 
       ------------------------------------------------------------- 
       AstraZeneca shares are up 1.8 percent after Citi raises share price
target to 27 pounds from 25.82 but European pharma stocks overall retreat as
investors switch funds out of the defensive sector in a stronger stock market. 
       GlaxoSmithKline falls 1.9 percent, Novartis 1.7 percent and Roche 1
percent. 
       Citi says results next month from the Jupiter study of AstraZeneca's
cholesterol drug Crestor should be good news. It forecasts global 2012 Crestor
sales of $6.8 billion versus consensus of $5.6 billion. AstraZeneca CEO David
Brennan told Reuters last month Jupiter would be "very important". 
       For more double click on 
       Reuters Messaging rm://ben.hirschler.reuters.com@reuters.net 
        
       08:43GMT 09Oct2008-Carillion up on strong order growth 
       ------------------------------------------------------ 
       Shares in British building and support services group Carillion rise 5
percent to 281.25 pence after the company says its main businesses are winning
plenty of good quality good orders, and it expects "materially enhanced"
earnings in 2009. 
       "Carillion continues to perform well with earnings being driven by
support services and healthy margins of between four and five percent," says
Grant Daniel at FinnCap in a research note. 
       "We feel the company has positioned itself well in these uncertain global
markets but we remain mindful of the fact that the level of gearing is high and
one should keep a watchful eye on their debt." 
       For more double click on 
       Reuters Messaging rm://paul.sandle.reuters.com@reuters.net 
        
       08:37GMT 09Oct2008-Air Berlin rises on Morgan Stanley upgrade 
       ------------------------------------------------------------ 
       Shares in German airline Air Berlin advance 2 percent in Frankfurt's
small-cap index after Morgan Stanley upgrades the company to "equalweight" from
"underweight", upping its price target to 3.80 euros per share from 3.10 euros. 
       "Although we are cautious on the sector, we have decided to move two of
our Underweight-V rated stocks -- Air Berlin and Vueling -- back to
Equal-weight-V, as both have fallen below our base case targets and are now
trading at historical lows," Morgan Stanley writes in a note. Vueling is also up
2 percent. 
       Shares in Air Berlin have fallen 75 percent so far this year, as the
airline industry came under extreme pressure by soaring oil prices that have
fallen again in recent weeks. 
       For more double click on 
       Reuters Messaging rm://christoph.steitz.reuters.com@reuters.net 
        
       08:35GMT 09Oct2008-K+S higher after Monsanto boosts 2012 outlook 
       ---------------------------------------------------------------- 
       Shares in K+S AG rise 10.5 percent, taking a top spot among gainers on
Germany's DAX index, as the fertilizer and industrial salts company benefits
after sector peer Monsanto Co released solid quarterly figures and significantly
boosted its 2012 outlook. 
       "The solid quarterly numbers, but especially the raised outlook is
helping K+S," says analyst Heinz Mueller from DZ Bank. 
       "Monsanto said it sees fundamental strong demand in the agricultural
sector. This is good news for fertilizer producers such as K+S," Mueller adds. 
       Monsanto raised its gross profit target for 2012 to between $9.5 billion
and $9.75 billion, up from about $8 billion. 
       It said optimism was boosted by internal surveys that found tight credit
markets should not weaken the company's ability to sell seeds and herbicides to
farmers. 
       For more double click on 
       Reuters Messaging rm://tyler.sitte.reuters.com@reuters.net 
        
     
tf.TFN-Europe_newsdesk@thomson.com
vjt

COPYRIGHT

Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.

<< Back


Glaxosmithkline Historical Chart Glaxosmithkline Intraday Chart  
Period
noad


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
31 site:2us 081204 12:18 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )